EUVIMEDEUVIMED entdecken
Vergleichsstudie

Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients

Önder Demiröz, Muhammed Bahadir Omar, Ersin Yildirim, Kanber Öcal Karabay

Cardiovascular Journal of Africa · 2025

DOI: 10.5830/cvja-2025-039 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cardiovascular Journal of Africa, 2025. Verfasst von Önder Demiröz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital. Email: onderdmrz1@windowslive.com. Hauptthemen laut MEDLINE: Coronary Angiography, Acute Coronary Syndrome, Coronary Artery Disease, Decision Support Techniques.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non-ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present. METHODS: 300 NSTE-ACS patients were enrolled in the study. SVEAT scores were calculated in an emergency room. After coronary angiography was performed for each patient, SYNTAX scores were calculated and the results compared. RESULTS: The total population was 300 patients, with a mean age of 60.35 ± 12.07, 68.7% of whom were of the male sex (n = 206). The median SYNTAX score of the study group was 8.00 (3.00-16.00). SVEAT scores showed a profound positive correlation with SYNTAX scores (r = 0.702, p < 0.001). An SVEAT score ≥ 5 predicted higher SYNTAX scores with 83% specificity and 73% sensitivity. Lower ejection fraction (r = -0.355, p < 0.001) and lower high-density lipoprotein (r = -0.174, p = 0.004) were linked to higher SYNTAX scores. CONCLUSION: This study is a first for the presentation of the SVEAT score as a reliable tool for estimating the SYNTAX score in NSTE-ACS patients. It will provide valuable insight to clinicians for risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary AngiographyAcute Coronary SyndromeCoronary Artery DiseaseDecision Support TechniquesElectrocardiographyNon-ST Elevated Myocardial InfarctionTroponinPlaque, AtheroscleroticHumansMalePredictive Value of TestsFemaleRisk AssessmentAgedBiomarkersMiddle AgedPrognosisRisk FactorsPercutaneous Coronary InterventionSeverity of Illness IndexReproducibility of Results

Stichwörter der Autor:innen

SVEAT scoreSYNTAX scoreacute coronary syndromecoronary angiography

Substanzen

BiomarkersTroponin

Autor:innen und Institutionen

  • Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital. Email: onderdmrz1@windowslive.com.
  • Lokman Hekim Hospital.
  • Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital.

Zitieren

APA

Demiröz, Ö., Omar, M. B., Yildirim, E., & Karabay, K. Ö. (2025). Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2025-039

Vancouver

Demiröz Ö, Omar MB, Yildirim E, Karabay KÖ. Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients. Cardiovascular Journal of Africa. 2025. doi:10.5830/cvja-2025-039

BibTeX
@article{Demirz2025,
  author = {Demiröz, Önder and Omar, Muhammed Bahadir and Yildirim, Ersin and Karabay, Kanber Öcal},
  title = {Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients},
  journal = {Cardiovascular Journal of Africa},
  year = {2025},
  doi = {10.5830/cvja-2025-039}
}
Kostenlos starten →